MACS Immuno-Oncology Day Brussels

Immunosuppression in the human tumor microenvironment

Friday, February 1, 2019
09:00 a.m.–06:00 p.m.

Salle des Guichets
Bip, Rue Royale 2–4
Brussels, Belgium

09:00 a.m.	Opening: Have we yet understood the key mechanisms to unleash the anti-tumor response? Pierre van der Bruggen, Brussels, Belgium
Tumor microenvironment: The innate immune system
09:30 a.m.	Human tumor-associated macrophage transcriptional landscape in solid tumors Luca Cassetta, Edinburgh, UK
10:05 a.m.	NK cell activation and exhaustion: two sides of the same coin Thierry Walzer, Lyon, France
10:40 a.m.	Coffee break
11:20 a.m.	The diversity of cancer-related neutrophils. Their impact on the tumor microenvironment and cancer progression. Zvi Fridlander, Jerusalem, Israel
Tumor microenvironment: T lymphocytes
11:55 a.m.	Targeting GARP on Tregs: a novel approach for the immunotherapy of cancer Sophie Lucas, Brussels, Belgium
12:30 p.m.	Deciphering the immune landscape of the human cancer microenvironment Massimiliano Pagani, Milan, Italy
01:05 p.m.	Lunch break
Metabolism and glycosylation
02:30 p.m.	Metabolic interventions to enhance anti-tumor immune responses Roger Geiger, Bellinzona, Switzerland
03:05 p.m.	Glycans as immune checkpoints for cancer immunotherapy Yvette van Kooyk, Amsterdam, Netherlands
03:40 p.m.	Coffee break
Dendritic cell and CAR T cell therapies
04:00 p.m.	Development of 21st century cancer vaccines Carl Figdor, Nijmegen, Netherlands
04:35 p.m.	Dissecting mechanisms of tumor immune surveillance and immunotherapies at the single cell level Philippe Bousso, Paris, France
05:10 p.m.	Moving CAR T cell therapy into solid tumors Gianpietro Dotti, Chapel Hill, North Carolina, USA
05:45 p.m.	Closing/Farewell Tim Oliver Stolle (Miltenyi Biotec), Leiden, Netherlands
06:00 p.m.	Celebration party